Radium 223 dichloride for prostate cancer treatment

Prostate cancer is the most common malignant disease in men. Several therapeutic agents have been approved during the last 10 years. Among them, radium-223 dichloride (Xofigo(®)) is a radioactive isotope that induces irreversible DNA double-strand breaks and consequently tumor cell death. Radium-223...

Descripción completa

Detalles Bibliográficos
Autores principales: Deshayes, Emmanuel, Roumiguie, Mathieu, Thibault, Constance, Beuzeboc, Philippe, Cachin, Florent, Hennequin, Christophe, Huglo, Damien, Rozet, François, Kassab-Chahmi, Diana, Rebillard, Xavier, Houédé, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593411/
https://www.ncbi.nlm.nih.gov/pubmed/28919714
http://dx.doi.org/10.2147/DDDT.S122417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593411/
https://www.ncbi.nlm.nih.gov/pubmed/28919714
http://dx.doi.org/10.2147/DDDT.S122417

Ejemplares similares